BMS 181100

Drug Profile

BMS 181100

Alternative Names: BMY 14802; BMY 14802 1; MJ 14802

Latest Information Update: 21 Sep 2000

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Anti-infectives; Antiallergics; Antiasthmatics; Antipsychotics; Ischaemic heart disorder therapies
  • Mechanism of Action Opioid receptor antagonists; Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Psychotic disorders

Most Recent Events

  • 21 Sep 2000 Discontinued-III for Psychotic disorders in USA (Unknown route)
  • 23 May 1995 Suspended-II for Psychotic disorders in USA (Unknown route)
  • 09 May 1995 A preclinical study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top